293 related articles for article (PubMed ID: 18454168)
1. Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1.
Langmead CJ; Austin NE; Branch CL; Brown JT; Buchanan KA; Davies CH; Forbes IT; Fry VA; Hagan JJ; Herdon HJ; Jones GA; Jeggo R; Kew JN; Mazzali A; Melarange R; Patel N; Pardoe J; Randall AD; Roberts C; Roopun A; Starr KR; Teriakidis A; Wood MD; Whittington M; Wu Z; Watson J
Br J Pharmacol; 2008 Jul; 154(5):1104-15. PubMed ID: 18454168
[TBL] [Abstract][Full Text] [Related]
2. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
[TBL] [Abstract][Full Text] [Related]
3. G protein coupling and signaling pathway activation by m1 muscarinic acetylcholine receptor orthosteric and allosteric agonists.
Thomas RL; Mistry R; Langmead CJ; Wood MD; Challiss RA
J Pharmacol Exp Ther; 2008 Nov; 327(2):365-74. PubMed ID: 18664591
[TBL] [Abstract][Full Text] [Related]
4. AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model.
Bradley SR; Lameh J; Ohrmund L; Son T; Bajpai A; Nguyen D; Friberg M; Burstein ES; Spalding TA; Ott TR; Schiffer HH; Tabatabaei A; McFarland K; Davis RE; Bonhaus DW
Neuropharmacology; 2010 Feb; 58(2):365-73. PubMed ID: 19835892
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.
Thomas RL; Langmead CJ; Wood MD; Challiss RA
J Pharmacol Exp Ther; 2009 Dec; 331(3):1086-95. PubMed ID: 19767446
[TBL] [Abstract][Full Text] [Related]
6. Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M
Popiolek M; Nguyen DP; Reinhart V; Edgerton JR; Harms J; Lotarski SM; Steyn SJ; Davoren JE; Grimwood S
Biochemistry; 2016 Dec; 55(51):7073-7085. PubMed ID: 27958713
[TBL] [Abstract][Full Text] [Related]
7. Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.
Jones CK; Brady AE; Davis AA; Xiang Z; Bubser M; Tantawy MN; Kane AS; Bridges TM; Kennedy JP; Bradley SR; Peterson TE; Ansari MS; Baldwin RM; Kessler RM; Deutch AY; Lah JJ; Levey AI; Lindsley CW; Conn PJ
J Neurosci; 2008 Oct; 28(41):10422-33. PubMed ID: 18842902
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors.
Lebon G; Langmead CJ; Tehan BG; Hulme EC
Mol Pharmacol; 2009 Feb; 75(2):331-41. PubMed ID: 19001633
[TBL] [Abstract][Full Text] [Related]
9. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.
Sheffler DJ; Williams R; Bridges TM; Xiang Z; Kane AS; Byun NE; Jadhav S; Mock MM; Zheng F; Lewis LM; Jones CK; Niswender CM; Weaver CD; Lindsley CW; Conn PJ
Mol Pharmacol; 2009 Aug; 76(2):356-68. PubMed ID: 19407080
[TBL] [Abstract][Full Text] [Related]
10. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
[TBL] [Abstract][Full Text] [Related]
11. Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
Langmead CJ; Fry VA; Forbes IT; Branch CL; Christopoulos A; Wood MD; Herdon HJ
Mol Pharmacol; 2006 Jan; 69(1):236-46. PubMed ID: 16207821
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
Ma L; Seager MA; Wittmann M; Jacobson M; Bickel D; Burno M; Jones K; Graufelds VK; Xu G; Pearson M; McCampbell A; Gaspar R; Shughrue P; Danziger A; Regan C; Flick R; Pascarella D; Garson S; Doran S; Kreatsoulas C; Veng L; Lindsley CW; Shipe W; Kuduk S; Sur C; Kinney G; Seabrook GR; Ray WJ
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15950-5. PubMed ID: 19717450
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of a novel series of heterobivalent muscarinic ligands based on xanomeline and 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).
Bonifazi A; Yano H; Del Bello F; Farande A; Quaglia W; Petrelli R; Matucci R; Nesi M; Vistoli G; Ferré S; Piergentili A
J Med Chem; 2014 Nov; 57(21):9065-77. PubMed ID: 25275964
[TBL] [Abstract][Full Text] [Related]
15. Bitopic Binding Mode of an M
Bradley SJ; Molloy C; Bundgaard C; Mogg AJ; Thompson KJ; Dwomoh L; Sanger HE; Crabtree MD; Brooke SM; Sexton PM; Felder CC; Christopoulos A; Broad LM; Tobin AB; Langmead CJ
Mol Pharmacol; 2018 Jun; 93(6):645-656. PubMed ID: 29695609
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes.
Odagaki Y; Kinoshita M; Toyoshima R
Naunyn Schmiedebergs Arch Pharmacol; 2013 Nov; 386(11):937-47. PubMed ID: 23748234
[TBL] [Abstract][Full Text] [Related]
17. Activation of cerebral function by CS-932, a functionally selective M1 partial agonist: neurochemical characterization and pharmacological studies.
Iwata N; Kozuka M; Hara T; Kanek T; Tonohiro T; Sugimoto M; Niitsu Y; Kondo Y; Yamamoto T; Sakai J; Nagano M
Jpn J Pharmacol; 2000 Nov; 84(3):266-80. PubMed ID: 11138727
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M
van der Westhuizen ET; Spathis A; Khajehali E; Jörg M; Mistry SN; Capuano B; Tobin AB; Sexton PM; Scammells PJ; Valant C; Christopoulos A
Mol Pharmacol; 2018 Jul; 94(1):770-783. PubMed ID: 29691279
[TBL] [Abstract][Full Text] [Related]
19. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
[TBL] [Abstract][Full Text] [Related]
20. THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner.
Steinfeld T; Hughes AD; Klein U; Smith JA; Mammen M
Mol Pharmacol; 2011 Mar; 79(3):389-99. PubMed ID: 21139051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
